Global Coverage With Measles Vaccine Declined During COVID-19
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, according to research published in the Nov. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Anna A. Minta, M.D., from the World Health Organization in Geneva, and colleagues describe progress toward measles elimination during 2000 to 2023.
The researchers note that an estimated 60.3 million measles deaths were averted by vaccination during 2000 to 2023. However, no region successfully achieved and maintained elimination by the end of 2023, despite commitment from all six World Health Organization regions to eliminate measles. Estimated global coverage with the first dose of measles-containing vaccine (MCV1) declined to 81 percent during the COVID-19 pandemic, which was the lowest level since 2008. In 2022, MCV1 coverage improved to 83 percent, but was unchanged in 2023. Estimated measles cases increased 20 percent worldwide from 2022 to 2023, from 8,645,000 to 10,341,000; there was an increase observed in the number of countries experiencing large or disruptive outbreaks, from 36 to 57. From 2022 to 2023, there was an 8 percent decrease seen in estimated measles deaths, mainly due to an increased number of cases occurring in countries with a lower risk for death.
"Countries and global partners working together is essential to accelerate efforts to reach and sustain measles elimination," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Worse Outcomes Seen for Unvaccinated Patients Hospitalized With COVID-19, AKI
WEDNESDAY, June 18, 2025 -- For patients hospitalized with COVID-19 infection and acute kidney injury (AKI), those who are unvaccinated have worse outcomes in terms of kidney...
Widespread Decline Seen in MMR Vaccination Rates After COVID-19
THURSDAY, June 5, 2025 -- A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published...
Parents Appear Receptive to Children Receiving HPV Vaccine at 9 or 10 Years of Age
MONDAY, June 2, 2025 -- Clinicians consider administration of human papillomavirus (HPV) vaccine as feasible at age 9 to 10 years, and parents appear to be receptive to discussing...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.